Baseline Clearance of Infliximab is Associated with Requirement for Colectomy in Patients with Acute Severe Ulcerative Colitis

BACKGROUND & AIMS: Hospitalized patients with acute severe ulcerative colitis (ASUC) often require surgery. Although the tumor necrosis factor antagonist infliximab is an effective salvage therapy to prevent colectomy in patients with ASUC, optimal dosing is unclear. Calculated infliximab cleara...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Gastroenterol Hepatol
Main Authors: Battat, Robert, Hemperly, Amy, Truong, Stephanie, Whitmire, Natalie, Boland, Brigid S., Dulai, Parambir S, Holmer, Ariela K, Nguyen, Nghia H, Singh, Siddharth, Casteele, Niels Vande, Sandborn, William J.
Formato: Artigo
Idioma:Inglês
Publicado: 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7606215/
https://ncbi.nlm.nih.gov/pubmed/32348905
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2020.03.072
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares